Opening book details…
About this book
Nivolumab Plus Chemotherapy or Ipilimumab in Gastroesophageal Cancer: Exploratory Biomarker Analyses of a Randomized Phase 3 Trial by Kohei Shitara & Yelena Y. Janjigian & Jaffer Ajani & Markus Moehler & Jin Yao & Xuya Wang & Aparna Chhibber & Dimple Pandya & Lin Shen & Marcelo Garrido & Carlos Gallardo & Lucjan Wyrwicz & Kensei Yamaguchi & Tomasz Skoczylas & Arinilda Bragagnoli &... is a book available to read on EtoBox.
- Author
- Kohei Shitara & Yelena Y. Janjigian & Jaffer Ajani & Markus Moehler & Jin Yao & Xuya Wang & Aparna Chhibber & Dimple Pandya & Lin Shen & Marcelo Garrido & Carlos Gallardo & Lucjan Wyrwicz & Kensei Yamaguchi & Tomasz Skoczylas & Arinilda Bragagnoli &...
- Publisher
- Springer US
- Published
- 2025
- Language
- EN
More by Kohei Shitara & Yelena Y. Janjigian & Jaffer Ajani & Markus Moehler & Jin Yao & Xuya Wang & Aparna Chhibber & Dimple Pandya & Lin Shen & Marcelo Garrido & Carlos Gallardo & Lucjan Wyrwicz & Kensei Yamaguchi & Tomasz Skoczylas & Arinilda Bragagnoli &...
Similar books
- Nivolumab Plus Ipilimumab in Advanced Salivary Gland Cancer: a Phase 2 Trial — Joris L. Vos & Bharat Burman & Swati Jain & Conall W. R. Fitzgerald & Eric J. Sherman & Lara A. Dunn & James V. Fetten & Loren S. Michel & Anuja Kriplani & Kenneth K. Ng & Juliana Eng & Vatche Tchekmedyian & Sofia Haque & Nora Katabi & Fengshen Kuo &... (2023)
- Pembrolizumab Plus Chemotherapy in Advanced or Recurrent Endometrial Cancer: Overall Survival and Exploratory Analyses of the NRG GY018 Phase 3 Randomized Trial — Ramez N. Eskander & Michael W. Sill & Lindsey Beffa & Richard G. Moore & Joanie M. Hope & Fernanda B. Musa & Robert S. Mannel & Mark S. Shahin & Guilherme H. Cantuaria & Eugenia Girda & Elizabeth Lokich & Juraj Kavecansky & Charles A. Leath & Lilian T.... (2025)
- Neoadjuvant Chemotherapy Plus Nivolumab with or Without Ipilimumab in Operable Non-small Cell Lung Cancer: the Phase 2 Platform NEOSTAR Trial — Tina Cascone & Cheuk H. Leung & Annikka Weissferdt & Apar Pataer & Brett W. Carter & Myrna C. B. Godoy & Hope Feldman & William N. William & Yuanxin Xi & Sreyashi Basu & Jing Sun & Shalini S. Yadav & Frank R. Rojas Alvarez & Younghee Lee & Aditya... (2023)
- Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Early-stage Triple-negative Breast Cancer: a Phase 2 Adaptive Trial — Iris Nederlof & Olga I. Isaeva & Manon Graaf & Robbert C. A. M. Gielen & Noor A. M. Bakker & Adrianne L. Rolfes & Hannah Garner & Bram Boeckx & Joleen J. H. Traets & Ingrid A. M. Mandjes & Michiel Maaker & Thomas Brussel & Maksim Chelushkin & Elisa... (2024)
- Neoadjuvant Nivolumab and Chemotherapy in Early Estrogen Receptor-positive Breast Cancer: a Randomized Phase 3 Trial — Sherene Loi & Roberto Salgado & Giuseppe Curigliano & Roberto Iván Romero Díaz & Suzette Delaloge & Carlos Ignacio Rojas García & Marleen Kok & Cristina Saura & Nadia Harbeck & Elizabeth A. Mittendorf & Denise A. Yardley & Alberto Suárez Zaizar &... (2025)
- High- or Low-dose Preoperative Ipilimumab Plus Nivolumab in Stage III Urothelial Cancer: the Phase 1B NABUCCO Trial — Jeroen Dorp & Christodoulos Pipinikas & Britt B. M. Suelmann & Niven Mehra & Nick Dijk & Giovanni Marsico & Maurits L. Montfoort & Sophie Hackinger & Linde M. Braaf & Tauanne Amarante & Charlaine Steenis & Kirsten McLay & Antonios Daletzakis & Daan... (2023)